1. Scrip

Inartful v colorful language: the 'SCOTUScare' ruling

 
• By Donna Young

Ruling in favor of the Obama administration in upholding the Affordable Care Act (ACA) on 25 June, US Supreme Court Chief Justice John Roberts took Congress to task for its poor language in writing the law – calling it "inartful."

Ruling in favor of the Obama administration in upholding the Affordable Care Act (ACA) on 25 June, US Supreme Court Chief Justice John Roberts took Congress to task for its poor language in writing the law – calling it "inartful."

"Several features of the act's passage contributed to that unfortunate reality," he said in writing the majority opinion in the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Scrip

Pipeline Watch: Eight Approvals And Two Phase III Readouts

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Sibeprenlimab’s US Accelerated Approval Drives IgAN Competition Forward

 
• By Lisa Takagi

Following US approval of its first-in-class drug for IgAN sibeprelimab, Otsuka is planning an sNDA for an autoinjector in 2026 and is in talks with regulatory authorities in Japan and Europe.

The Rise of China Biopharma – Five Themes In 2025

 
• By Andrew McConaghie

The growth of China’s biopharma sector has been perhaps the most significant sector trend this year – Scrip outlines five themes that have emerged during 2025 and in discussions at the recent Jefferies conference in London.